AMGN

Amgen Inc.

Halal Rating :
Uncomfortable
Last Price $271.90 Last updated:
Market Cap $146.27b
7D Change 0.63%
1 Year Change -12.34%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Biological Products
  • Except Diagnostic Substances
Exchange Nasdaq
Next Earnings Date Nov. 5, 2024

Amgen Inc. is one of the world's largest independent biotechnology companies. Founded in 1980, it focuses on developing innovative human therapeutics for serious illnesses. The company's key product areas include oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology, and neuroscience. Amgen discovers, develops, manufactures, and delivers innovative human therapeutics.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $8.5b $7.23b - $776.0m 0.00% 10.73%
June 30, 2024 $8.39b $7.29b - $808.0m 0.00% 11.09%
March 31, 2024 $7.45b $7.28b - $824.0m 0.00% 11.32%

Company Impact

Help us evaluate Amgen Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates